Recently, the company's application for "METHOD FOR ENZYMATIC PREPARATION OF GLUTATHIONE" received a patent certificate issued by the United States Patent and Trademark Office, patent number: US11788110B2.
Each year, only about half of all patent applications filed in the United States are ultimately approved by the U.S. Patent Office. After rigorous review at all levels, we were awarded a U.S. patent this time, which proves the uniqueness and superiority of our production technology.
In recent years, the technology of enzymatic production of glutathione has gradually improved. As the pioneer of global enzymatic catalytic coupling ATP regeneration technology, our company's new enzymatic production technology realizes ATP regeneration with low cost and less pollution. It has A number of independent intellectual property rights.
We have always adhered to green environmental protection, technological innovation and global layout. The company is equipped with advanced scientific research equipment and an experienced scientific research team. The production technologies of glutathione, β-Nicotinamide Mononucleotide, citicoline sodium and other research and development are internationally leading.
After 13 years of research and development, a total of 22 Chinese invention patents, 1 utility model patent and 2 international invention patents have been applied for. It has been authorized 12 Chinese invention patents, 1 utility model patent, 1 international invention patent (authorized by the United States), and 8 software copyrights.
In the future, we will pay more attention to the innovative research and development of high value-added raw materials, important pharmaceutical intermediates and cosmetic raw materials, and continue to optimize production technology to provide global customers with higher quality and satisfactory products.